Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein.
about
Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivationXAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivationContribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionThe Role of Sexually Transmitted Infections in HIV-1 Progression: A Comprehensive Review of the LiteratureA trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA.Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancerTrans-activation function of a 3' truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissuesHepatitis B virus HBx protein deregulates cell cycle checkpoint controlsDifferent regions of hepatitis B virus X protein are required for enhancement of bZip-mediated transactivation versus transrepression.Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein.Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen.Activation of the human immunodeficiency virus type 1 long terminal repeat by vaccinia virus.Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.Regulation of hepatocyte nuclear factor 1 activity by wild-type and mutant hepatitis B virus X proteinsThe hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB.Enhancement of hepatitis B virus replication by its X protein in transgenic miceHepatitis B virus infection and primary hepatocellular carcinoma.The role of hepatitis B virus in the development of primary hepatocellular carcinoma: Part I.Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascadeHepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteinsHepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinasesWoodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and woodchuck hepatocellular carcinomas which are permissive for viral replication.Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication.Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases.The effects of cytomegalovirus on human immunodeficiency virus replication in brain-derived cells correlate with permissiveness of the cells for each virusTAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by the Tat proteinThe hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors.Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor.Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range.Hepatitis B virus X protein is not central to the viral life cycle in vitro.Identification and characterization of a human herpesvirus 6 gene segment that trans activates the human immunodeficiency virus type 1 promoter.Transactivation of the human immunodeficiency virus promoter by human herpesvirus 6 (HHV-6) strains GS and Z-29 in primary human T lymphocytes and identification of transactivating HHV-6(GS) gene fragments.Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters.Hepatitis B virus transactivator X protein is not tumorigenic in transgenic miceCD4-independent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses.Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene.Structural rearrangement of integrated hepatitis B virus DNA as well as cellular flanking DNA is present in chronically infected hepatic tissues.Differentiation-specific transcriptional regulation of the hepatitis B virus large surface antigen gene in human hepatoma cell linesCD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro.In vitro susceptibility of T lymphocytes from chimpanzees (Pan troglodytes) to human herpesvirus 6 (HHV-6): a potential animal model to study the interaction between HHV-6 and human immunodeficiency virus type 1 in vivo.
P2860
Q24310197-012C38C6-5649-4C4B-A0FC-E50EA26D2390Q24544043-3290336A-6A6B-411B-9315-8D789B651356Q24550678-25FBB22D-0BDC-4E7F-8768-539475826CB1Q26864344-FA319F27-F9C3-43D5-934D-7C1D8A149C7AQ31010141-BD89A5FB-F1D3-453F-ACFA-AD53BD743F6AQ33581303-9182AC5A-EF4C-49F8-BD13-CCF06838A4C9Q33707652-63981870-E040-4503-97F1-461F83FF04ACQ33765576-1394C7D8-D3AB-486C-A459-813ECC68C1D4Q33794363-A2EA05AD-7EFF-49B9-A188-1493466BE9D4Q33834716-29EC6F16-5569-42B5-A94E-A133D5C0E749Q33877464-7F29F7BB-D7A9-482B-A93C-D2A84BA8C8C5Q33930958-C2868D39-53EC-42A8-A9DB-156B47F59B6AQ34288246-D5FC0410-3BBC-446D-810D-E75E5CF151E0Q34339787-6F6AF325-35F0-4FB9-9326-A912DF96D84EQ34382034-87D70FB7-C485-45C7-910D-F2D9A958C495Q34970818-35FE680C-0D9E-4214-A34C-20E191940872Q35231554-0C23FA3C-F654-4800-8C81-7DEB2430189AQ35238054-F2B76373-5808-45DD-AC75-87618A4DFDCEQ35850088-0A1F0B8A-825B-4765-8AFF-8777413FDACEQ35864366-8E9C4F26-1CBE-4FC4-A8F1-35C4F1A82DC8Q35865743-D06F8A5C-3AA4-487E-8F43-D90D27DB7698Q35866048-02034EC9-5184-4841-9D25-055489C1C181Q35867756-2BA68EEC-E085-4BC9-A6AA-54524E56D6C4Q36508624-9DEDF427-9500-4D23-A3E2-9C5E0E760539Q36626966-2A484758-2873-4A7E-9B84-157CFA3CF416Q36639281-B0702388-2B97-4302-B926-7CBE10641E18Q36684890-F9EF7BC4-A4CC-4D0E-B1EF-5A79B6CA63F8Q36686383-580EC78A-421D-4E07-8844-83FD9F4DBE35Q36687863-0E3DC328-E1E9-4D5E-BCA3-1CB574D3BD14Q36690826-4EE02DB1-4A01-4207-8AB9-ABFDA64F49CAQ36692142-F666E12F-9305-4DCD-8DE4-C610EF10705BQ36693219-8EFBC449-7241-44B7-B43D-984AF2250472Q36698990-AC494D2B-3D87-4089-B4A5-7C5B8E07EF41Q36796019-129B01E2-B08A-4F66-856A-304465F0CC25Q36796481-BDD44788-9964-41FF-ABD5-262EC613E897Q36797650-D5EB71AC-413D-42DF-A3C2-632DEC015D8DQ36801171-CD56C8B3-7ED1-43C9-B342-5B371C007FF1Q36806128-794A3EF3-C04E-4F94-83E8-1470C203DF42Q36806704-7A0F16F5-D9B3-454A-9394-118723377E9AQ36807211-E7901E21-6DCF-4B84-B693-2542EF0258D8
P2860
Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein.
description
1988 nî lūn-bûn
@nan
1988 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Trans-activation of the human ...... e hepatitis B virus X protein.
@ast
Trans-activation of the human ...... e hepatitis B virus X protein.
@en
type
label
Trans-activation of the human ...... e hepatitis B virus X protein.
@ast
Trans-activation of the human ...... e hepatitis B virus X protein.
@en
prefLabel
Trans-activation of the human ...... e hepatitis B virus X protein.
@ast
Trans-activation of the human ...... e hepatitis B virus X protein.
@en
P2093
P2860
P356
P1476
Trans-activation of the human ...... e hepatitis B virus X protein.
@en
P2093
P2860
P304
P356
10.1073/PNAS.85.21.8286
P407
P577
1988-11-01T00:00:00Z